Mapping preclinical compensation in Parkinson's disease: An imaging genomics approach

Movement Disorders

Volumn 24, Issue SUPPL. 2, 2009, Pages

  Van Nuenen, Bart F L ^a,b   Van Eimeren, Thilo ^c   Van Der Vegt, Joyce P M ^a,b   Buhmann, Carsten ^d   Klein, Christine ^e   Bloem, Bastiaan R ^a   Siebner, Hartwig R ^b,f  

^a RADBOUD UNIVERSITY   (Netherlands)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Compensation; Functional magnetic resonance imaging; Motor cortex; Parkin gene; Parkinson's disease; PINK1 gene; Presymptomatic parkinsonism

Indexed keywords

PARKIN; PROTEIN SERINE THREONINE KINASE;

ALLELE; ASSOCIATION; AUTOSOMAL DOMINANT DISORDER; BRAIN FUNCTION; CINGULATE GYRUS; DOPAMINERGIC NERVE CELL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HAND MOVEMENT; HETEROZYGOSITY; HUMAN; IN VIVO STUDY; MEDICAL RESEARCH; MOTOR CORTEX; MOTOR PERFORMANCE; NEUROIMAGING; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TASK PERFORMANCE;

ANTIPARKINSON AGENTS; FINGERS; GENOMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MOVEMENT; MUTATION; PARKINSON DISEASE; PROTEIN KINASES; PSYCHOMOTOR PERFORMANCE; UBIQUITIN-PROTEIN LIGASES;

EID: 72849153163     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22635     Document Type: Review

References (43)

1. Gasser T. Update on the genetics of Parkinson's disease. Mov Disord 2007;22:S343-S350.
2. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 2007;6:652-662. (Pubitemid 46921058)
3. Klein C, Lohmann-Hedrich K. Impact of recent genetic findings in Parkinson's disease. Curr Opin Neurol 2007;20:453-464. (Pubitemid 47051994)
4. Logothetis NK. What we can do and what we cannot do with fMRI. Nature 2008;453:869-878.
5. Goldberg TE, Weinberger DR. Genes and the parsing of cognitive processes. Trends Cogn Sci 2004;8:325-335.
6. van Eimeren T, Siebner HR. An update on functional neuroimaging of parkinsonism and dystonia. Curr Opin Neurol 2006;19:412-419.
7. Hariri AR, Weinberger DR. Imaging genomics. Br Med Bull 2003;65:259-270.
8. Albanese A, Valente EM, Romito LM, Bellacchio E, Elia AE, Dallapiccola B. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology 2005;64:1958-1960. (Pubitemid 40800717)
9. Hedrich K, Hagenah J, Djarmati A, et al. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit? Arch Neurol 2006;63:833-838.
10. Bonifati V, Rohe CF, Breedveld GJ, et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 2005;65:87-95. (Pubitemid 40967781)
11. Hilker R, Klein C, Ghaemi M, et al. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 2001;49:367-376. (Pubitemid 32202791)
12. Khan NL, Scherfler C, Graham E, et al. Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology 2005;64:134-136. (Pubitemid 40082951)
13. Binkofski F, Reetz K, Gaser C, et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology 2007;69:842-850. (Pubitemid 47329583)
14. Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 2004;1912:1445-1449. (Pubitemid 40104051)
15. Braak H, Del TK, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. (Pubitemid 36007810)
16. Fearnley JM, Lees A. Pathology of Parkinson's disease. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders; 1991. p545-554.
17. Forno LS. Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons 50 incidental cases: relationship to parkinsonism. J Am Geriatr Soc 1969;17:557-575.
18. Koller WC. When does Parkinson's disease begin? Neurology 1992;42(Suppl 4):27-31.
19. Gibb WR. Functional neuropathology in Parkinson's disease. Eur Neurol 1997;38(Suppl 2):21-25.
20. Blandini F, Nappi G, Tassorelli C, Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol 2000;62:63-88. (Pubitemid 30252017)
21. Buhmann C, Binkofski F, Klein C, et al. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain 2005;128(Part 10):2281-2290. (Pubitemid 41407968)
22. Samuel M, Ceballos-Baumann AO, Blin J, et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 1997;120(Part 6):963-976. (Pubitemid 27259547)
23. Sabatini U, Boulanouar K, Fabre N, et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 2000;123(Part 2):394-403. (Pubitemid 30055162)
24. Georgiou N, Bradshaw JL, Iansek R, Phillips JG, Mattingley JB, Bradshaw JA. Reduction in external cues and movement sequencing in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:368-370. (Pubitemid 24083424)
25. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995;118(Part 4):913-933.
26. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992;32:151-161.
27. van Nuenen BF, Weiss MM, Bloem BR, et al. Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. Neurology 2009;72:1041-1047.
28. Park J, Lee SB, Lee S, et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006;441:1157-1161. (Pubitemid 43990737)
29. Yang Y, Gehrke S, Imai Y, et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 2006;103:10793-10798. (Pubitemid 44078055)
30. Exner N, Treske B, Paquet D, et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 2007;2745:12413-12418. (Pubitemid 350085485)
31. Clark IE, Dodson MW, Jiang C, et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006;441:1162-1166. (Pubitemid 43990738)
32. Kim Y, Park J, Kim S, et al. PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 2008;377:975-980.
33. Carbon M, Eidelberg D. Functional imaging of sequence learning in Parkinson's disease. J Neurol Sci 2006;248(1/2):72-77. (Pubitemid 44647286)
34. Catalan MJ, Ishii K, Honda M, Samii A, Hallett M. A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 1999;122(Part 3):483-495. (Pubitemid 29110523)
35. Boecker H, Dagher A, Ceballos-Baumann AO, et al. Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: investigations with H2 15O PET. J Neurophysiol 1998;79:1070-1080. (Pubitemid 28095918)
36. Sadato N, Yonekura Y, Waki A, Yamada H, Ishii Y. Role of the supplementary motor area and the right premotor cortex in the coordination of bimanual finger movements. J Neurosci 1997;17:9667-9674. (Pubitemid 28006410)
37. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 1997;6:218-229.
38. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 2003;54:176-185.
39. Jenkins IH, Fernandez W, Playford ED, et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 1992;32:749-757.
40. Buhmann C, Gorsler A, Baumer T, et al. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease. Brain 2004;127(Part 12):2732-2746. (Pubitemid 39627381)
41. Haslinger B, Erhard P, Kampfe N, et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001;124(Part 3):558-570. (Pubitemid 32221323)
42. Baumer T, Pramstaller PP, Siebner HR, et al. Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study. Neurology 2007;69:1976-1981. (Pubitemid 350145089)
43. Mentis MJ, Dhawan V, Feigin A, et al. Early stage Parkinson's disease patients and normal volunteers: comparative mechanisms of sequence learning. Hum Brain Mapp 2003;20:246-258. (Pubitemid 37486896)